Call us toll free (9am - 5pm EST): 1-888-262-7187

Dr. Monica Bhatia MD 
General Practice - Female
CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
 CUIMC/Herbert Irving Pavilion
 (212) 305-9770
 Is Accepting New Patients
 Next Location
Loading Map...
 
DOCTOR SUMMARY
 Degrees
Medical Doctor - MD
 Spoken Languages
English
 Years of Experience
N/A
 Insurances Accepted
AETNA
Affinity Health Plan
Amida Care
CIGNA
Emblem/GHI
Emblem/Hip
Empire Blue Cross Blue Shield Healthplus
Empire Blue Cross/Blue Shield
Fidelis Care
Healthfirst
Local 1199
Magnacare (National)
Medicare
Multiplan
MVP Health Care
Oxford Health Plans
UnitedHealthcare
VNSNY CHOICE
WellCare
 Twitter Handle
 Message
Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.

EZDoctor Report

Dr. Monica Bhatia MD
  • Malpractice Claims, Board Sanctions
  • Medical School Education
  • Patient Reviews, Publications
  • and much more
  • View a Sample Report [pdf]